Comparing eye drops to reverse pupil dilation in children
Part of Brain & nervous system, Eyes & vision clinical trials.
This trial tests how well two different eye drops (pilocarpine and phentolamine) work to reverse the effects of the dilation drops used in children's eye exams. It aims to find a faster way to bring the pupils back to normal.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Your child must be between 5 and 12 years old.
- Your child needs an eye exam that uses special drops to widen the pupils (cycloplegia).
- You and your child must agree to the study procedures.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests whether a special eye drop (MydCombi) works as well as or better than the standard drops for widening pupils during an eye exam. It includes both children and adults who need their pupils dilated.
This study tests eye drops to improve how a child’s eyes line up and how well they can use both eyes together. It may help children with certain types of outward eye drifting (intermittent exotropia/exophoria).
This study tests whether atropine eye drops can slow down worsening nearsightedness in children. It is for children whose nearsightedness is getting worse quickly and who have not tried other treatments.
This trial tests if atropine 0.05% eye drops can slow down nearsightedness in children who have had cataract surgery and a lens implant. It is for children ages 1 to 7.
This study looks at how different pain treatments affect a child’s pupils (the dark center of the eye). It may help doctors better understand which pain medicines are working and how to measure pain treatment effects more accurately.
This study tests a new eye drop medicine (T10430) to see if it can slow down how fast children's nearsightedness gets worse. The trial will measure whether the drops are safe and effective for kids ages 6–11.
Hear when a new Pupillary Constriction trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.